Neurofibromatosis Type 1 and Multiple Primary Malignancies

Medical and Pediatric Oncology

Volumn 41, Issue 6, 2003, Pages 568-569

  Barbaric, Draga ^a   Stevens, Michael ^b   Dalla Pozza, Luciano ^b  

^a BC CHILDREN S HOSPITAL   (Canada)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Childhood cancer; Multiple malignancies; Neurofibromatosis type 1

Indexed keywords

ANTINEOPLASTIC AGENT; NEUROFIBROMIN; PROTEIN P53;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BRAIN CANCER; CANCER CHEMOTHERAPY; CANCER RISK; CANCER STAGING; CHILD; CHILDHOOD CANCER; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; MULTIPLE CANCER; NEUROFIBROMATOSIS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; T CELL LYMPHOMA;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASTROCYTOMA; CHILD; CHILD, PRESCHOOL; COLONIC NEOPLASMS; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; NEOPLASMS, MULTIPLE PRIMARY; NEUROFIBROMATOSIS 1;

EID: 0242490564     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.10423     Document Type: Article

References (15)

1. Matsui I, Tanimura M, Kobayashi N, et al, Neurofibromatosis type 1 and childhood cancer. Cancer 1993;72:2746-2754.
2. Shen MH, Harper PS, Upadhyaya M, Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet 1996;33:2-17.
3. Sorensen SA, Mulvihill JJ, Nielsen A, Long-term follow-up of von Recklinghausen neurofibromatosis-survival and malignant neoplasms. N Engl J Med 1986;314:1010-1015.
4. Perilongo G, Felix CA, Meadows AT, et al. Sequential development of Wilms tumour, T-cell acute lymphoblastic leukemia, medulloblastoma, and myeloid leukemia in a child with type 1 neurofibromatosis: A clinical and cylogenetic case report. Leukemia 1993;7:912-915.
5. Blatt J, Jaffe R, Deutsch M, et al. Neurofibromatosis and childhood tumors. Cancer 1986;57:1225-1229.
6. Shearer P, Parham D, Kovnar E, et al. Neurofibromatosis type 1 and malignancy: Review of 32 pediatric cases treated at a single institution. Med Pediatr Oncol 1994;22:78-83.
7. Pratt CB, Parham DM, Rao BN, et al. Multiple colorectal carcinomas, polyposis coli, and neurofibromatosis. J Natl Cancer Inst 1988;80:1170-1171.
8. Hoops TC, Traber PG. Molecular pathogenesis of colorectal cancer. Hematol Oncol Clin North Am 1997;11:609-633.
9. Jacob S, Prabhakar BR, Singh SK, et al. Neurofibromatosis of the colon: An unusual manifestation of von Recklinghausen's diseases-a case report. Indian J Pathol Microbiol 1998;41:113-116.
10. Marina N. Long-term survivors of childhood cancer. The medical consequences of cure. Pediatr Clin North Am 1997;44:1021-1042.
11. Messiaen LM, Callens C, Mortier G, et al. Exhaustive mutation analysis of the NF-1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 2000;15:541-555.
12. Legius E, Dierick H, Wu R, et al. TP53 mutations are frequent in malignant NF1 tumors. Genes Chromosomes Cancer 1994;10:250-255.
13. Li Y, Bollag G, Clark R, et al. Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell 1992;69:275-281.
14. Harris CC. Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies. J Natl Cancer Inst 1996;88:1442-1455.
15. Malkin D, Jolly KW, Barbier N, et al. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med 1992;326:1309-1315.